Chinese Assessment for Vinpocetine In Neurology "CAVIN"

Completed

Phase N/A Results N/A

Eligibility Criteria

Inclusion Criteria

- Male or female, age 40-80
- The onset of the infarction between 48 hours and 1 month
- CT / MRI results show cerebral infarction with deficit of neurological function.
- CT or MRI confirms no intracranial hemorrhage
- NIHSS score ≥ 3
- The subject agree to sign the informed consent form

Exclusion Criteria

- Evidence of acute or chronic intracranial hemorrhage, subarachnoid hemorrhage, intracranial arteriovenous malformation, aneurysm or neoplasm based on CT / MRI examination
- NIHSS score ≥ 17
- Coma patient
- Existed disorders or conditions that would interfere neurological assessments (eg. dementia, psychiatric disorder, etc.)
- Intracranial tumor, arteriovenous malformation, aneurysm, or intracranial surgery
- Active peptic ulcer disease
- Complicated with severe hepatic and renal disorder (ALT, AST 3.0 times higher than normal value; BUN or Cr more than 1.5 times the normal value) and severe disorder in hematopoietic system and endocrine system.
- Bleeding tendency or blood disease
- Plan to perform operation and carotid angioplasty
- With severe congestive heart failure or acute myocardial infarction
- Participate in other clinical trials at the same time, or withdrawal within 3 months
- Allergic or contraindicated to vinpocetine or other treatment medication
- Investigator think the subject is not suitable to participate in this trial